Linical : Notice of Distribution of Retained Earnings(177kb)
May 30, 2023 at 06:01 am IST
Share
Company Name: Linical Co., Ltd. Representative: Kazuhiro Hatano President & CEO (TSE code: 2183)
May 29, 2023
Notice of Distribution of Retained Earnings
At the meeting of its Board of Directors held on May 29, 2023, Linical Co.,Ltd. (hereinafter, the "Company") resolved the distribution of retained earnings with a record date of March 31, 2023 as follows.
1. Details of Dividend
Latest forecast
Total amount of
dividends for the fiscal
Resolved
(announced on May 16,
year ended March 31,
2022)
2022
Record date
March 31, 2023
Same as on the left
March 31, 2022
Dividend per share
JPY 14.00
Same as on the left
JPY 14.00
Total dividend
JPY 316,210 thousand
-
JPY 316,210 thousand
Effective date
June 8, 2023
-
June 9, 2022
Dividend resource
Retained earnings
-
Retained earnings
2. Reason
The Company's basic policy is to optimize the balance between the improvement in our corporate value through mid/long-term growth and return to shareholders, and we aim to return profits in a stable manner with consideration of business performance,.
The Company resolved to pay dividend of JPY 14.00 per share as the year-end dividend for the fiscal year ended March 31, 2023, as originally planned.
The Articles of Incorporation of the Company stipulate that the Company can pay dividends from retained earnings based on the resolution by the Board of Directors.
(Reference) Breakdown of annual dividend
Dividend per share
Record Date
Interim
Year-end
Total
Fiscal year ended March 31,
JPY 00.00
JPY 14.00
JPY 14.00
2023
Fiscal year ended March 31,
JPY 00.00
JPY 14.00
JPY 14.00
2022
End
Notes: This is a translation of the press release originally drafted in Japanese for the disclosure required in compliance with the TSE regulations.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Linical Co. Ltd. published this content on 29 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 May 2023 00:30:02 UTC.
Linical Co., Ltd. is a Japan-based company mainly engaged in the contract research organization (CRO) business for drug companies. The Company operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.